This Week in Cannabis: March 17, 2026 Highlights
This week’s roundup covers cannabis legalization efforts 2026, focusing on medical applications and safety concerns. Key developments include tax revenue allocation for infrastructure repairs. Stay informed on therapeutic uses and regulatory updates.
Pediatricians Warn on Cannabis Exposure Risks and Easy Access in Children
Pediatric cannabis exposure risks are increasing due to easy access to high-potency cannabis products. This exposure can impair brain development, cognition, and emotional regulation in children. Pediatricians stress early screening and education to…
InMed Pharmaceuticals Focuses on Cannabinoid Therapeutic Development
InMed Pharmaceuticals' shift to cannabinoid therapeutic development marks a significant change in the industry. This move away from commodity cannabinoid production affects clinicians sourcing standardized cannabinoid products. The focus on cannabinoid…
Virginia Adult-Use Cannabis Sales Bills Pass Both Chambers, Head to Conference Committee!
Virginia's adult-use cannabis sales legislation marks a major regulatory shift impacting clinical practice. The bills now head to a conference committee, signaling imminent legalization. This change will increase patient access and influence medical…
Ohio THC Drink Ban Draws Lawsuit from Cincinnati Breweries
The ohio thc beverage ban lawsuit highlights legal challenges from Cincinnati breweries against state cannabis regulations. This ban restricts the sale of THC-infused drinks, raising industry and patient concerns. The lawsuit could influence future…
Louisiana Lawmaker Files Bill to Legalize Recreational Marijuana
The recreational marijuana legalization Louisiana bill proposes licensed dispensaries to regulate adult cannabis use. This legislation marks a shift from medical-only access to a broader legal market. Clinicians should prepare for changes in patient…
4 Cannabis Articles Clinical Relevance – March 17, 2026
This post reviews 4 cannabis articles clinical relevance as of March 17, 2026. The articles cover therapeutic evidence and policy developments relevant to clinicians. These insights help inform evidence-based cannabis medicine practice.
Czech Republic Decides to Ban HHC – Possession to Become Punishable in the Future
The Czech Republic HHC ban marks a significant shift in synthetic cannabinoid regulation. Possession of HHC will become punishable, impacting patient access and safety. Clinicians should stay informed about this evolving legal landscape.
Pennsylvania Senators Amend Cannabis Bill to Restrict Hemp-Derived Cannabinoids
Pennsylvania senators have proposed hemp-derived cannabinoid restrictions in cannabis legislation that would ban intermediate and synthetic cannabinoids. These changes narrow the legal definition of hemp products and affect delta-8 and delta-10…
Many Say They Use Cannabis for Their Mental Health, But There’s No Evidence It Helps
Many patients report using cannabis for mental health conditions such as anxiety and depression, but mental health cannabis evidence does not support its effectiveness. Clinicians face challenges due to the gap between patient perceptions and scientific…